JERUSALEM

More in JERUSALEM

• Israel resumes indoor mask requirement amid virus spike

  The head of Israel's pandemic response taskforce, Nachman Ash, told public radio the requirement came after four days of more than 100 new cases a day, with 227 cases confirmed Thursday.

  

• Israel, Cyprus reach tourism deal for vaccinated travelers

  Israel and Cyprus announced a tourism agreement Sunday to allow citizens who have been vaccinated against the coronavirus to travel between the countries without the need to quarantine.

  

• Reliance signs USD 15 million deal with an Israeli firm to distribute Covid-19 breath test kit

  According to the agreement, the Indian corporate giant will purchase hundreds of systems from the Israeli company in a deal valued at USD 15 million and will use them to conduct millions of tests a month at a cost of USD 10 million per month, business portal Calcalist reported.

  

• Israel sharing Covid-19 data with Pfizer

  Israel is giving weekly data updates on its Covid-19 outbreak to vaccine maker Pfizer under a collaboration agreement that may help other countries fine-tune their inoculation campaigns and achieve “herd immunity”, officials said.

  

• Israel's OurCrowd to raise $100 million for coronavirus technologies

  Israeli venture investing platform OurCrowd said on Tuesday it plans to raise $100 million for investment in technology in medical, education and other segments to find solutions for COVID-19 and future pandemics.

  

• Israeli airline eyes mass job cuts over coronavirus

  Israeli airline El Al said Sunday it was considering firing 1,000 staff out of its total workforce of around 6,000 due to losses linked to the novel coronavirus outbreak.

  

• Treatment for obesity, fatty liver disease in the offing

  Scientists say they have discovered 27 new molecules with the potential to treat fatty liver disease, obesity, diabetic nephrotoxicity, as well as heal wounds.

  

• A blood test may help reduce antibiotic use

  A new blood test can help cut down on unnecessary use of antibiotics by detecting within two hours if bacteria or virus is the source of an infection, scientists say.